We are expanding our services in Switzerland
With the appointment of Per Rigler as Business Development Manager, we expand our business in Switzerland.
We are excited to announce the appointment of Per Rigler, PhD, as Business Development Manager to spearhead our continued growth in Switzerland. Dr Rigler is based in the “Stellwerk”, close to multiple global pharma and chemical companies.
Dr Rigler joins BioLizard with more than a decade’s experience in the Swiss biotech industry, including extensive experience in bioinformatics, AI and data analysis. He previously worked at Genedata, Carl Zeiss and is a Board member of Gnothis AG, a Swiss biotech company that has pioneered the area of single molecule sequencing and gene analysis. He earned his PhD in physical chemistry and biophysics from Ecole Polytechnique Fédérale de Lausanne (EPFL).
“We are very pleased to have Per join the BioLizard team and expand on our presence in Switzerland.”
“As a provider of bioinformatics and AI solutions to the pharmaceutical industry, Switzerland has always been a key market. We have completed multiple projects in support of the world-leading research conducted by Swiss-based scientists, and with Per’s support, we look forward to many more!”
To find out more about BioLizard’s world-leading bioinformatics, AI, and data analysis services, Dr Rigler will be presenting at the following virtual events or can be contacted at the following address Stellwerk, Bahnhof St. Johann, Vogesenplatz 1, 4056 Basel or via email: per.rigler@biolizard.com.
Events:
Related news
BioLizard Awarded €300,000 VLAIO Research Grant
We are happy to announce the receipt of a research grant from VLAIO to leverage our world-leading expertise in bioinform
Read more
Unraveling causality in microbiome research
Our latest blog post is out! Read more about the work Steff Taelman will be doing funded by our VLAIO grant.
Read more